«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2023 13

Page:

2508-2512

Research Field:

Publishing date:

Info

Title:

Analysis on the incidence,death and survival trend of thyroid cancer among urban residents in Shenyang，China from 2009 to 2019

Author(s):

LYU Yi¹; ZHANG Xinyu²; NIE Huifang¹; ZHAO Xue¹; LI Xun¹; WANG Xiaoli¹

1.Institute of Chronic Disease,Shenyang Center for Disease Control and Prevention,Liaoning Shenyang 110168,China;2.College of Foreign Languages,University of Information Engineering,Henan Luoyang 471003,China.

Keywords:

thyroid cancer; incidence rate; mortality; survival rate

PACS:

R736.1

DOI:

10.3969/j.issn.1672-4992.2023.13.026

Abstract:

Objective:To provide prevention and control measures for thyroid cancer,by analyzing the incidence,death and survival trend of thyroid cancer in tumor registration areas in Shenyang，China from 2009 to 2019.Methods:The incidence and death cases of thyroid cancer from 2009 to 2019 in the tumor registration area of Shenyang,a national cancer surveillance point,were collected.The incidence rate,mortality rate,age-standardized rates (by Chinese standard population and world standard population),truncated rate (35~64 years old),cumulative rate (0~74 years old) and survival rate of thyroid cancer were calculated.Joinpoint3.5.3 software was used to calculate the annual percentage change (APC%) of incidence rate,mortality rate,and survival rate.SPSS 23.0 statistical software was used for the χ2 test on the incidence rate and mortality rate of thyroid cancer in males and females.Results:From 2009 to 2019,the crude incidence of thyroid cancer in Shenyang，China,the age-standardized incidence rates by Chinese standard population and world standard population were 15.15/100 000,12.11/100 000,and 10.23/100 000,respectively.The incidence rate was higher in females than that in males (P＜0.01).The crude mortality rate of thyroid cancer,the age-standardized mortality rates by Chinese standard population and world standard population were 0.76/100 000,0.43/100 000,0.41/100 000,respectively.And the mortality rate was higher in females than that in males (P＜0.01).The 10-year incidence rate of thyroid cancer of males and females in Shenyang,China had been on the rise (P＜0.05).The incidence rank of thyroid cancer rose to the fifth place in males and the third place in females.And the mortality rank remained basically unchanged in both gender.From 2011 to 2015,the 5-year observed survival rate of thyroid cancer in males and females showed an upward trend,ranking the first in the survival rate of malignant tumors.Conclusion:From 2009 to 2019,the incidence of thyroid cancer in Shenyang,China had been on the rise,which was higher in females than that in males,and the mortality rank remained basically unchanged.The 5-year observed survival rate showed an upward trend,ranking the first in the survival rate of malignant tumors.

References:

［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71（3）：209-249.
［2］国家癌症中心.中国肿瘤登记年报（2020)［M］.北京：人民卫生出版社，2020：208-209. National Cancer Center.China cancer registry annual report (2020)［M］.Beijing:People's Medical Publishing House,2020：208-209.
［3］全国肿瘤登记中心.中国肿瘤登记年报（2012)［M］.北京：军事医学科学出版社，2012：105-108. National Central Cancer Registy.China cancer registry annual report (2012)［M］.Beijing:Military Medical Science Press,2012：105-108.
［4］国家癌症中心.中国肿瘤登记工作指导手册 (2016)［M］.北京:人民卫生出版社,2016：59-75. National Cancer Center.Guideline for Chinese cancer registration (2016)［M］.Beijing:People's Medical Publishing House,2016：59-75.
［5］FELAY J,BURKHARD C,WHELAN S,et al.Check and conversion programs for cancer registries.IARC technical report 7-No.42［M］.Lyon:IARC,2005:3.
［6］BRAY F,PARKIN DM.Evaluation of data quality in the cancer registry:Principles and methods.Part I:comparability,validity and timeliness［J］.Eur J Cancer,2009,45(5):747-755.
［7］王悠清,李辉章,龚巍巍,等.2015 年浙江省肿瘤登记地区恶性肿瘤发病与死亡分析［J］.中国肿瘤,2019,28(1):12-22. WANG YQ,LI HZ,GONG WW,et al.Analysis of incidence and death of malignant tumors in tumor registration areas of Zhejiang Province in 2015［J］.China Cancer，2019,28(1):12-22.
［8］吴春晓，顾凯，庞怡,等.2016 年上海市甲状腺癌发病和死亡情况与2002-2016 年间变化趋势分析［J］.外科理论与实践,2022,27(1):58-65. WU CX,GU K,PANG Y,et al.Incidence and death of thyroid cancer in Shanghai in 2016 and its change trend from 2002 to 2016 ［J］.Journal of Surgery Concepts & Practice,2022,27(1):58-65.
［9］贾海晗，孙惠昕，张茂祥，等.2013-2017年黑龙江省肿瘤登记地区甲状腺癌流行趋势［J］.中华肿瘤防治杂志，2022，29（6）：387-392. JIA HH,SUN HX,ZHANG MX,et al.Prevalence trend of thyroid cancer in tumor registration areas of Heilongjiang Province from 2013 to 2017［J］.Chinese Journal of Cancer Prevention and Treatment,2022，29（6）：387-392.
［10］雷林，尚庆刚，刘秋耿，等.深圳市 2001-2015 年甲状腺癌发病现状和趋势分析［J］.中国肿瘤,2019,28(7):504-508. LEI L，SHANG QG，LIU QG，et al.Incidences and epidemiologic trends of thyroid cancer in Shenzhen，2001-2015［J］.China Cancer，2019,28(7):504-508.
［11］刘芮，陈杨，石青萍，等.云南省肿瘤登记地区2012-2016年甲状腺癌发病与死亡特征及时间趋势［J］．实用肿瘤学杂志，2021，35（6）：489-494. LIU R，CHEN Y，SHI QP，et al.Characteristics and time trend of thyroid cancer incidence and mortality from 2012 to 2016 in cancer registration areas of Yunnan Province［J］.Practical Oncology Journal，2021，35(6)：489-494．
［12］李伟伟，周金意，董建梅，等．2015年江苏省甲状腺癌流行现状及2006-2015年趋势分析［J］．实用肿瘤学杂志，202l，35(1)：1-6． LI WW，ZHOU JY,DONG JM，et al.Epidemic status of thyroid cancer in Jiangsu Province in 2015 and its trend analysis from 2006 to 2015［J］.Practical Oncology Journal，2021，35(1)：1-6．
［13］宋勇峰,王凯．甲状腺疾病和脂代谢［J］ .临床心血管病杂志,2022,38(09):692-695. SONG YF，WANG K.Thyroid disease and lipid metabolism ［J］．Journal of Clinical Cardiology，2022,38(09):692-695.
［14］曾幸，刘慧霞，萧梅芳，等．甲状腺癌在2型糖尿病患者中患病情况及相关因素分析［J］．中国普通外科杂志，2019，29(5)：558-564． ZENG X,LIU HX,XIAO MF,et al.Analysis of prevalence and related factors of thyroid cancer in patients with type 2 diabetes［J］．Chinese Journal of General Surgery，2019，29(5)：558-564．
［15］JINA KIM，JESSICA E GOSNELL，SANZIANA A ROMA．Geographic influences in the global rise of thyroid cancer［J］．Nat Rev Endocrinol，2020，16(1)：17-29．
［16］张宏伟，石福民，薛荣，等．肥胖指标体质量指数和腰围与甲状腺癌的关系［J］．中国耳鼻咽喉头颈外科杂志，2022，29(06)：373-377． ZHANG HW,SHI FM,XUE R,et al.Relationship between body mass index,waist circumference and thyroid cancer ［J］．Chinese Archives of Otolaryngology-Head and Neck Surgery,2022，29(06)：373-377．
［17］张洁，闫贻忠，王丹，等．2005-2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析［J］．现代预防医学，2020，47(4)：577-582． ZHANG J，YAN YZ，WANG D，et al．Time trend analvsis of thyroid cancer incidence in tumor registration areas of China from 2005 to 2014［J］．Modern Preventive Medicine，2020，47(4)：577-582．
［18］张志焕，赵海峰．甲状腺癌发病相关危险因素的病例对照研究［J］．中国药物与临床，2021，21(9)：1478-1480． ZHANG ZH，ZHAO HF．A case control study of risk factors for thyroid cancer［J］．Chinese Remedies & Clinics，2021，21(9)：1478-1480．
［19］LI MM,MASO LD,VACCARELLA S.Global trends in thyroid cancer incidence and the impact of overdiagnosis［J］.The Lancet Diabetes Endocrinology,2020,8(6):468-470.
［20］ZENG HM,CHEN WQ,ZHENG RS,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries［J］.The Lancet Global Health,2018,6(5):e555-e567.

Memo

Memo:

辽宁省自然科学基金指导计划（编号：20180550495）

Common functions

Last Update: 2023-05-31